We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.06%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.11T
AUM Growth
+$49.3B
Cap. Flow
-$2.91B
Cap. Flow %
-0.26%
Top 10 Hldgs %
27.74%
Holding
3,121
New
186
Increased
817
Reduced
1,825
Closed
148

Top Buys

Rank Stock Value
1
RIVN icon
Rivian
RIVN
+$18.7B
2
AAPL icon
Apple
AAPL
+$5.48B
3
NVDA icon
NVIDIA
NVDA
+$5.33B
4
TSLA icon
Tesla
TSLA
+$4.47B
5
MSFT icon
Microsoft
MSFT
+$2.15B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$4.26B
2
META icon
Meta Platforms (Facebook)
META
+$3.3B
3
MS icon
Morgan Stanley
MS
+$2.82B
4
GPN icon
Global Payments
GPN
+$2.43B
5
PYPL icon
PayPal
PYPL
+$2B

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Healthcare 16.09%
3 Consumer Discretionary 15.79%
4 Communication Services 12.38%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMLTU
3076
DELISTED
CM Life Sciences III Inc. Unit
CMLTU
-3,292,388
Closed -$34.3M
IIAC
3077
DELISTED
Investindustrial Acquisition Corp.
IIAC
-165,100
Closed -$1.64M
KSU
3078
DELISTED
Kansas City Southern
KSU
-171,463
Closed -$46.4M
HRC
3079
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
-35,194
Closed -$5.28M
PPD
3080
DELISTED
PPD, Inc. Common Stock
PPD
-1,246,175
Closed -$58.3M
CXP
3081
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
-35,183
Closed -$669K
DSPG
3082
DELISTED
DSP Group Inc
DSPG
-39,506
Closed -$866K
AGCUU
3083
DELISTED
Altimeter Growth Corp Unit
AGCUU
-2,386,351
Closed -$25.4M
AGC
3084
DELISTED
Altimeter Growth Corp
AGC
-4,461,800
Closed -$45.6M
MDP
3085
DELISTED
Meredith Corporation
MDP
-15,350
Closed -$855K
CVA
3086
DELISTED
Covanta Holding Corporation
CVA
-130,199
Closed -$2.62M
DDMX
3087
DELISTED
DD3 Acquisition Corp. II Class A Common Stock
DDMX
-13,305
Closed -$132K
INOV
3088
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
-25,751
Closed -$1.04M
ADMS
3089
DELISTED
Adamas Pharmaceuticals
ADMS
-26,000
Closed -$128K
XLRN
3090
DELISTED
Acceleron Pharma
XLRN
-5,365,133
Closed -$923M
CAI
3091
DELISTED
CAI International, Inc.
CAI
-4,377
Closed -$245K
FLXN
3092
DELISTED
Flexion Therapeutics, Inc.
FLXN
-34,451
Closed -$210K
LORL
3093
DELISTED
Loral Space and Communications, Inc.
LORL
-4,874
Closed -$210K
EBSB
3094
DELISTED
Meridian Bancorp, Inc.
EBSB
-5,047,120
Closed -$105M
KDMN
3095
DELISTED
Kadmon Holdings, Inc.
KDMN
-14,916
Closed -$130K
MDLA
3096
DELISTED
Medallia, Inc.
MDLA
-39,258
Closed -$1.33M
RPAI
3097
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
-87,254
Closed -$1.12M
CSOD
3098
DELISTED
Cornerstone OnDemand, Inc.
CSOD
-46,577
Closed -$2.67M
CLDR
3099
DELISTED
Cloudera, Inc.
CLDR
-100,663
Closed -$1.61M
SBBP
3100
DELISTED
Strongbridge Biopharma plc.
SBBP
-36,100
Closed -$74K

Similar funds

T. Rowe Price Associates's Q4 2021 Portfolio in Review

As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
  • T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
  • T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
  • T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
  • T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
  • T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.